All lobbying filings

KING & SPALDING LLP

KING & SPALDING LLP filed a Q1 report for PRELUDEDX on April 21, 2025, reporting $20,000 in lobbying income.

Lobbying for PRELUDEDX · Molecular diagnostics company

All filings by KING & SPALDING LLP · Everything PRELUDEDX has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 21, 2025

Income

$20,000

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Coverage of breast cancer risk assessment test.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.